105 related articles for article (PubMed ID: 26804792)
1. Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.
Cendejas-Bueno E; Forastiero A; Ruiz I; Mellado E; Buitrago MJ; Gavaldà J; Gomez-Lopez A
Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):571-576. PubMed ID: 26804792
[TBL] [Abstract][Full Text] [Related]
2. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
McCulloch E; Ramage G; Rajendran R; Lappin DF; Jones B; Warn P; Shrief R; Kirkpatrick WR; Patterson TF; Williams C
J Clin Pathol; 2012 Jan; 65(1):83-6. PubMed ID: 22049217
[TBL] [Abstract][Full Text] [Related]
3. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
Duarte RF; Sánchez-Ortega I; Cuesta I; Arnan M; Patiño B; Fernández de Sevilla A; Gudiol C; Ayats J; Cuenca-Estrella M
Clin Infect Dis; 2014 Dec; 59(12):1696-702. PubMed ID: 25165088
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
Gastine S; Hope W; Hempel G; Petraitiene R; Petraitis V; Mickiene D; Bacher J; Walsh TJ; Groll AH
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168606
[No Abstract] [Full Text] [Related]
5. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Vallor AC; Kirkpatrick WR; Najvar LK; Bocanegra R; Kinney MC; Fothergill AW; Herrera ML; Wickes BL; Graybill JR; Patterson TF
Antimicrob Agents Chemother; 2008 Jul; 52(7):2593-8. PubMed ID: 18474582
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
8. Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Gebremariam T; Alkhazraji S; Gu Y; Singh S; Alqarihi A; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685475
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of galactomannan enzyme immunoassay and quantitative real-time PCR for the diagnosis of invasive pulmonary aspergillosis in a rat model.
Lin JC; Xing YL; Xu WM; Li M; Bo P; Niu YY; Zhang CR
J Microbiol Biotechnol; 2014 Aug; 24(8):1044-50. PubMed ID: 24743569
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus.
Bedin Denardi L; Pantella Kunz de Jesus F; Keller JT; Weiblen C; de Azevedo MI; Oliveira V; Morais Santurio J; Hartz Alves S
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):40-43. PubMed ID: 29126660
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.
Kimura G; Nakaoki T; Nishimoto Y; Suzuki Y; Rapeport G; Strong P; Ito K; Kizawa Y
Mycoses; 2017 Nov; 60(11):728-735. PubMed ID: 28699245
[TBL] [Abstract][Full Text] [Related]
13. New therapies for fungal pneumonia.
Maertens J; Meersseman W; Van Bleyenbergh P
Curr Opin Infect Dis; 2009 Apr; 22(2):183-90. PubMed ID: 19276884
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis.
Calmettes C; Gabriel F; Blanchard E; Servant V; Bouchet S; Kabore N; Forcade E; Leroyer C; Bidet A; Latrabe V; Leguay T; Vigouroux S; Tabrizi R; Breilh D; Accoceberry I; de Lara MT; Pigneux A; Milpied N; Dumas PY
Oncotarget; 2018 Jun; 9(42):26724-26736. PubMed ID: 29928481
[TBL] [Abstract][Full Text] [Related]
15. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
16. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.
Kohno S; Izumikawa K
Clin Infect Dis; 2010 Dec; 51(12):1392-4. PubMed ID: 21054178
[No Abstract] [Full Text] [Related]
18. Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers.
Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
Clin Microbiol Infect; 2019 Sep; 25(9):1157.e1-1157.e7. PubMed ID: 30685498
[TBL] [Abstract][Full Text] [Related]
19. Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Wu CJ; Lee HC; Lo HJ; Ko WC
Diagn Microbiol Infect Dis; 2011 Aug; 70(4):528-30. PubMed ID: 21658879
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of refractory invasive fungal infection with posaconazole: additive value of therapeutic drug monitoring.
Henckaerts L; Spriet I; Meersseman W; Peetermans WE
Acta Clin Belg; 2011; 66(3):231-2. PubMed ID: 21837936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
